MSA SAFETY INC Revenue from Contract with Customer, Excluding Assessed Tax
MSA SAFETY INC (MSA) reported Revenue from Contract with Customer, Excluding Assessed Tax of $503.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-31
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $503.33M, a 6.16% increase year-over-year.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $463.63M, a 10.04% increase year-over-year.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $510.91M, a 2.24% increase year-over-year.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $468.44M, a 8.27% increase year-over-year.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.87B, a 3.69% increase from fiscal 2024.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.81B, a 1.15% increase from fiscal 2023.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.79B, a 17.00% increase from fiscal 2022.
- MSA SAFETY INC revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.53B, a 9.13% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $503.33M 10-Q · filed 2026-07-31 | $966.96M 10-Q · filed 2026-07-31 | $1.48B derived: sum of 3 quarters · filed 2026-07-31 | $1.95B derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $463.63M 10-Q · filed 2026-05-05 | $974.54M derived: sum of 2 quarters · filed 2026-05-05 | $1.44B derived: sum of 3 quarters · filed 2026-05-05 | $1.92B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $510.91M 10-K · filed 2026-02-12 | $979.36M derived: sum of 2 quarters · filed 2026-02-12 | $1.45B derived: sum of 3 quarters · filed 2026-07-31 | $1.87B 10-K · filed 2026-02-12 |
| 2025-09-30 | $468.44M 10-K · filed 2026-02-12 | $942.56M derived: sum of 2 quarters · filed 2026-07-31 | $1.36B 10-Q · filed 2025-10-29 | $1.86B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $474.12M 10-Q · filed 2026-07-31 | $895.46M 10-Q · filed 2026-07-31 | $1.40B derived: sum of 3 quarters · filed 2026-07-31 | $1.83B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $421.34M 10-Q · filed 2026-05-05 | $921.04M derived: sum of 2 quarters · filed 2026-05-05 | $1.35B derived: sum of 3 quarters · filed 2026-05-05 | $1.82B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $499.70M 10-K · filed 2026-02-12 | $932.38M derived: sum of 2 quarters · filed 2026-02-12 | $1.39B derived: sum of 3 quarters · filed 2026-02-12 | $1.81B 10-K · filed 2026-02-12 |
| 2024-09-30 | $432.68M 10-K · filed 2026-02-12 | $895.14M derived: sum of 2 quarters · filed 2026-02-12 | $1.31B 10-Q · filed 2025-10-29 | $1.80B derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $462.46M 10-K · filed 2026-02-12 | $875.76M 10-Q · filed 2025-08-05 | $1.37B derived: sum of 3 quarters · filed 2026-02-12 | $1.82B derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $413.30M 10-K · filed 2026-02-12 | $908.66M derived: sum of 2 quarters · filed 2026-02-12 | $1.36B derived: sum of 3 quarters · filed 2026-02-12 | $1.80B derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $495.36M 10-K · filed 2025-02-14 | $942.09M derived: sum of 2 quarters · filed 2025-02-14 | $1.39B derived: sum of 3 quarters · filed 2025-02-14 | $1.79B 10-K · filed 2026-02-12 |
| 2023-09-30 | $446.73M 10-K · filed 2025-02-14 | $894.03M derived: sum of 2 quarters · filed 2025-02-14 | $1.29B 10-Q · filed 2024-10-24 | $1.74B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $447.30M 10-K · filed 2025-02-14 | $845.56M 10-Q · filed 2024-07-25 | $1.29B derived: sum of 3 quarters · filed 2025-02-14 | $1.67B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $398.26M 10-K · filed 2025-02-14 | $841.52M derived: sum of 2 quarters · filed 2025-02-14 | $1.22B derived: sum of 3 quarters · filed 2025-02-14 | $1.60B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $443.25M 10-K · filed 2024-02-16 | $824.95M derived: sum of 2 quarters · filed 2024-02-16 | $1.20B derived: sum of 3 quarters · filed 2024-02-16 | $1.53B 10-K · filed 2025-02-14 |
| 2022-09-30 | $381.69M 10-K · filed 2024-02-16 | $754.01M derived: sum of 2 quarters · filed 2024-02-16 | $1.08B 10-Q · filed 2023-10-25 | $1.49B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $372.31M 10-K · filed 2024-02-16 | $703.00M 10-Q · filed 2023-08-01 | $1.11B derived: sum of 3 quarters · filed 2024-02-16 | $1.45B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $330.69M 10-K · filed 2024-02-16 | $740.96M derived: sum of 2 quarters · filed 2024-02-16 | $1.08B derived: sum of 3 quarters · filed 2024-02-16 | $1.42B derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $410.27M 10-K · filed 2023-02-16 | $750.47M derived: sum of 2 quarters · filed 2023-02-16 | $1.09B derived: sum of 3 quarters · filed 2023-02-16 | $1.40B 10-K · filed 2024-02-16 |
| 2021-09-30 | $340.20M 10-K · filed 2023-02-16 | $681.49M derived: sum of 2 quarters · filed 2023-02-16 | $989.91M 10-Q · filed 2022-10-27 | $1.38B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $341.29M 10-K · filed 2023-02-16 | $649.72M 10-Q · filed 2022-07-28 | $1.04B derived: sum of 3 quarters · filed 2023-02-16 | $1.34B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $308.43M 10-K · filed 2023-02-16 | $696.68M derived: sum of 2 quarters · filed 2023-02-16 | $1.00B derived: sum of 3 quarters · filed 2023-02-16 | $1.32B derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $388.25M 10-K · filed 2022-02-18 | $692.64M derived: sum of 2 quarters · filed 2022-02-18 | $1.01B derived: sum of 3 quarters · filed 2022-02-18 | $1.35B 10-K · filed 2023-02-16 |
| 2020-09-30 | $304.39M 10-K · filed 2022-02-18 | $618.83M derived: sum of 2 quarters · filed 2022-02-18 | $959.98M 10-Q · filed 2021-10-29 | $1.34B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $314.44M 10-K · filed 2022-02-18 | $655.58M 10-Q · filed 2021-07-29 | $1.03B derived: sum of 3 quarters · filed 2022-02-18 | $1.38B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $341.14M 10-K · filed 2022-02-18 | $716.40M derived: sum of 2 quarters · filed 2022-02-18 | $1.07B derived: sum of 3 quarters · filed 2022-02-18 | $1.42B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $375.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $726.27M derived: sum of 2 quarters · filed 2022-02-18 | $1.08B derived: sum of 3 quarters · filed 2022-02-18 | $1.40B 10-K · filed 2022-02-18 |
| 2019-09-30 | $351.01M 10-Q · filed 2020-10-30 | $700.69M derived: sum of 2 quarters · filed 2020-10-30 | $1.03B 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $349.68M 10-Q · filed 2020-07-31 | $675.71M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $326.04M 10-Q · filed 2020-04-30 | |||
| 2018-09-30 | $331.10M 10-Q · filed 2019-10-24 | $670.43M derived: sum of 2 quarters · filed 2019-10-24 | $996.32M 10-Q · filed 2019-10-24 | |
| 2018-06-30 | $339.33M 10-Q · filed 2019-07-25 | $665.23M 10-Q · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |